Stéphanie Kermorgant

6.5k total citations · 1 hit paper
40 papers, 2.9k citations indexed

About

Stéphanie Kermorgant is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Stéphanie Kermorgant has authored 40 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 23 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Stéphanie Kermorgant's work include Liver physiology and pathology (24 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Stéphanie Kermorgant is often cited by papers focused on Liver physiology and pathology (24 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Stéphanie Kermorgant collaborates with scholars based in United Kingdom, France and Finland. Stéphanie Kermorgant's co-authors include Peter J. Parker, Thérèse Lehy, Miguel J.M. Lewin, André Bado, Jean–Pierre Laigneau, Samir Attoub, Michèle Guerre-Millo, Marie-Noëlle Bortoluzzi, L. Moizo and Y. Le Marchand‐Brustel and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Stéphanie Kermorgant

39 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The stomach is a source of leptin

1998 941 citations André Bado, Samir Attoub et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphanie Kermorgant United Kingdom	24	1.1k	838	564	509	507	40	2.9k
Thérèse Lehy France	32	940 0.8×	945 1.1×	722 1.3×	556 1.1×	641 1.3×	101	3.7k
Nora Rozengurt United States	27	2.2k 2.0×	244 0.3×	645 1.1×	564 1.1×	688 1.4×	50	4.4k
Veronica Prpić United States	29	1.5k 1.4×	149 0.2×	246 0.4×	501 1.0×	208 0.4×	46	2.7k
Patrick Lau Australia	28	1.0k 0.9×	271 0.3×	56 0.1×	511 1.0×	232 0.5×	43	2.4k
Marie–Christine Rio France	24	1.2k 1.1×	361 0.4×	322 0.6×	332 0.7×	488 1.0×	37	2.8k
Nelson Ruiz‐Opazo United States	28	1.5k 1.4×	63 0.1×	178 0.3×	296 0.6×	226 0.4×	94	3.1k
Sven Eyckerman Belgium	23	981 0.9×	322 0.4×	192 0.3×	174 0.3×	310 0.6×	70	1.8k
Laura L. Mitic United States	13	1.4k 1.2×	136 0.2×	134 0.2×	360 0.7×	243 0.5×	17	2.7k
Rebecca P. Hughey United States	37	3.5k 3.1×	79 0.1×	529 0.9×	254 0.5×	223 0.4×	94	4.5k
Derrick R. Witcher United States	36	2.2k 2.0×	997 1.2×	962 1.7×	883 1.7×	154 0.3×	59	4.6k

Countries citing papers authored by Stéphanie Kermorgant

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Kermorgant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Kermorgant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Kermorgant more than expected).

Fields of papers citing papers by Stéphanie Kermorgant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Kermorgant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Kermorgant. The network helps show where Stéphanie Kermorgant may publish in the future.

Co-authorship network of co-authors of Stéphanie Kermorgant

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Kermorgant. A scholar is included among the top collaborators of Stéphanie Kermorgant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Kermorgant. Stéphanie Kermorgant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kermorgant, Stéphanie, et al.. (2022). c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance. Frontiers in Cell and Developmental Biology. 10. 994528–994528. 15 indexed citations

Kermorgant, Stéphanie, et al.. (2021). The role of MET in chemotherapy resistance. Oncogene. 40(11). 1927–1941. 71 indexed citations

Hervieu, Alexia & Stéphanie Kermorgant. (2020). Unconventional role of RAC1 in MET-driven anchorage-independent tumor growth. Molecular & Cellular Oncology. 7(6). 1803029–1803029. 1 indexed citations

Hervieu, Alexia, Chi Zhang, Rachel Barrow‐McGee, et al.. (2020). A PI3K- and GTPase-independent Rac1-mTOR mechanism mediates MET-driven anchorage-independent cell growth but not migration. Science Signaling. 13(637). 15 indexed citations

Hervieu, Alexia & Stéphanie Kermorgant. (2018). The Role of PI3K in Met Driven Cancer: A Recap. Frontiers in Molecular Biosciences. 5. 86–86. 31 indexed citations

Powles, Thomas, et al.. (2017). Understanding and targeting Met signalling in bladder cancer. Annals of Oncology. 28. v16–v16.

Barrow‐McGee, Rachel, Carine Joffre, Ludovic Ménard, et al.. (2016). Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes. Nature Communications. 7(1). 11942–11942. 89 indexed citations

Ménard, Ludovic, Peter J. Parker, & Stéphanie Kermorgant. (2014). Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nature Communications. 5(1). 3907–3907. 81 indexed citations

Barrow‐McGee, Rachel & Stéphanie Kermorgant. (2014). Met endosomal signalling: In the right place, at the right time. The International Journal of Biochemistry & Cell Biology. 49. 69–74. 62 indexed citations

10.

Ho-Yen, Colan, Andrew R. Green, Emad A. Rakha, et al.. (2013). C‐Met in invasive breast cancer. Cancer. 120(2). 163–171. 36 indexed citations

11.

Radtke, Simone, Michael Howell, Virginie Carrière, et al.. (2011). Anomalous inhibition of c‐Met by the kinesin inhibitor aurintricarboxylic acid. International Journal of Cancer. 130(5). 1060–1070. 4 indexed citations

12.

Rossé, Carine, Mark Linch, Stéphanie Kermorgant, et al.. (2010). PKC and the control of localized signal dynamics. Nature Reviews Molecular Cell Biology. 11(2). 103–112. 347 indexed citations

13.

Kermorgant, Stéphanie & Peter J. Parker. (2008). Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. The Journal of Cell Biology. 182(5). 855–863. 134 indexed citations

14.

Kermorgant, Stéphanie, Daniel Zicha, & Peter J. Parker. (2004). PKC controls HGF‐dependent c‐Met traffic, signalling and cell migration. The EMBO Journal. 23(19). 3721–3734. 115 indexed citations

15.

Kermorgant, Stéphanie, Daniel Zicha, & Peter J. Parker. (2003). Protein Kinase C Controls Microtubule-based Traffic but Not Proteasomal Degradation of c-Met. Journal of Biological Chemistry. 278(31). 28921–28929. 52 indexed citations

16.

Kermorgant, Stéphanie, et al.. (2001). Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis. 22(7). 1035–1042. 107 indexed citations

17.

Goïot, Hélène, Samir Attoub, Stéphanie Kermorgant, et al.. (2001). Antral mucosa expresses functional leptin receptors coupled to STAT-3 signaling, which is involved in the control of gastric secretions in the rat. Gastroenterology. 121(6). 1417–1427. 42 indexed citations

18.

Kermorgant, Stéphanie, Valérie Dessirier, Miguel J.M. Lewin, & Thérèse Lehy. (2001). HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 281(4). G1068–G1080. 11 indexed citations

19.

Kermorgant, Stéphanie & Thérèse Lehy. (2001). Glycine-Extended Gastrin Promotes the Invasiveness of Human Colon Cancer Cells. Biochemical and Biophysical Research Communications. 285(1). 136–141. 56 indexed citations

20.

Bado, André, Samir Attoub, Stéphanie Kermorgant, et al.. (1998). The stomach is a source of leptin. Nature. 394(6695). 790–793. 941 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact